Sandoz Deal In Price-Fixing Case Is Largest Ever For Domestic Antitrust Case

$195m deferred prosecution agreement with the US DOJ could be followed by civil settlement that's almost as large, illustrating the strong evidence in the generic price-fixing investigation thus far.

Compliance medicine health care integration computing concept. Doctor touched icon compliance gear on virtual screen. Medical governance automation robotic modernization healthy strategy, technology

Sandoz Inc.'s deferred prosecution agreement with the US Department of Justice illustrates the apparent strength of the government's generic price-fixing investigation, because the firm is poised to give back the vast majority of sales revenue for the products that were involved in the alleged scheme.

The DoJ announced on 2 March that Sandoz agreed to pay a $195m criminal penalty – "the largest for a...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Compliance

More from Pink Sheet